Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Concentrations in Dural Puncture Epidural for Labor Analgesia
NCT05499234Completed
- Sponsor
- Istanbul Medipol University
- Start
- Aug 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine hydrochloride 0.75% injection in labor pain (2 arms), sponsored by Istanbul Medipol University. Primary endpoint: Change the need of bupivacaine for epidural analgesia at 1 hour. Started Aug 2022; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
labor pain
Beyond the preview
Go deeper on NCT05499234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05499234.